From candidate molecules to approved medicines, our business supports knowledge based decision making of pharmaceutical risk benefit analysis.
Medicines Assessment provides expertise in pharmacology, clinical pharmacology and medicines regulation. Our aim is to increase efficiency when bringing medicines to market.
We advise on:
• clinical trial design
• new drug applications
• generics and variations
• scientific advice
• European applications
• investment decisions
• due diligence
You are viewing the text version of this site.
Need help? check the requirements page.
You need Flash to use this feature